Diabetes and Atherosclerosis: Old Players in a New Field, Osteoporosis

被引：16

作者：

Paschou, Stavroula A. ^{[1
]}

Anagnostis, Panagiotis ^{[2
]}

Vryonidou, Andromachi ^{[3
]}

Goulis, Dimitrios G. ^{[2
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Aghia Sophia Hosp, Med Sch, Div Endocrinol & Diabet, Athens, Greece

[2] Aristotle Univ Thessaloniki, Dept Obstet & Gynaecol 1, Unit Reprod Endocrinol, Med Sch, Thessaloniki, Greece

[3] Hellen Red Cross Hosp, Dept Endocrinol & Diabet, Athens, Greece

来源：

CURRENT VASCULAR PHARMACOLOGY | 2018年 / 16卷 / 06期

关键词：

CARDIOVASCULAR OUTCOMES; FRACTURE RISK; VITAMIN-D; BONE; METAANALYSIS; MELLITUS; TYPE-1; THIAZOLIDINEDIONES; ROSIGLITAZONE; COMPLICATIONS;

D O I：

10.2174/1570161116666171205104851

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

引用

页码：524 / 527

页数：4

共 42 条

[1]

Vascular calcification - Mechanisms and clinical ramifications [J].

Abedin, M ;

Tintut, Y ;

Demer, LL .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) :1161-1170

[2]

Efficacy of statins for osteoporosis: a systematic review and meta-analysis [J].

An, T. ;

Hao, J. ;

Sun, S. ;

Li, R. ;

Yang, M. ;

Cheng, G. ;

Zou, M. .

OSTEOPOROSIS INTERNATIONAL, 2017, 28 (01) :47-57

[3]

Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? [J].

Anagnostis, P. ;

Karagiannis, A. ;

Kakafika, A. I. ;

Tziomalos, K. ;

Athyros, V. G. ;

Mikhailidis, D. P. .

OSTEOPOROSIS INTERNATIONAL, 2009, 20 (02) :197-207

[4]

Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review [J].

Anagnostis, Panagiotis ;

Paschou, Stavroula A. ;

Gkekas, Nifon N. ;

Artzouchaltzi, Aikaterini-Maria ;

Christou, Konstantinos ;

Stogiannou, Dimitrios ;

Vryonidou, Andromachi ;

Potoupnis, Michael ;

Goulis, Dimitrios G. .

ENDOCRINE, 2018, 60 (03) :373-383

[5]

Vitamin D and Cardiovascular Disease: A Novel Agent for Reducing Cardiovascular Risk? [J].

Anagnostis, Panagiotis ;

Athyros, Vasilios G. ;

Adamidou, Fotini ;

Florentin, Matilda ;

Karagiannis, Asterios .

CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (05) :720-730

[6]

[Anonymous], ENDOCR REV

[7]

[Anonymous], INT J ENDOCRINOL

[8]

A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive type 2 diabetes mellitus patients [J].

Borges, J. L. C. ;

Bilezikian, J. P. ;

Jones-Leone, A. R. ;

Acusta, A. P. ;

Ambery, P. D. ;

Nino, A. J. ;

Grosse, M. ;

Fitzpatrick, L. A. ;

Cobitz, A. R. .

DIABETES OBESITY & METABOLISM, 2011, 13 (11) :1036-1046

[9]

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs [J].

Colhoun, H. M. ;

Livingstone, S. J. ;

Looker, H. C. ;

Morris, A. D. ;

Wild, S. H. ;

Lindsay, R. S. ;

Reed, C. ;

Donnan, P. T. ;

Guthrie, B. ;

Leese, G. P. ;

McKnight, J. ;

Pearson, D. W. M. ;

Pearson, E. ;

Petrie, J. R. ;

Philip, S. ;

Sattar, N. ;

Sullivan, F. M. ;

McKeigue, P. .

DIABETOLOGIA, 2012, 55 (11) :2929-2937

[10]

Increased fracture risk in patients with type 2 diabetes mellitus: An overview of the underlying mechanisms and the usefulness of imaging modalities and fracture risk assessment tools [J].

de Waard, Ellis A. C. ;

van Geel, Tineke A. C. M. ;

Savelberg, Hans H. C. M. ;

Koster, Annemarie ;

Geusens, Piet P. M. M. ;

van den Bergh, Joop P. W. .

MATURITAS, 2014, 79 (03) :265-274

← 1 2 3 4 5 →